Publications of Pavel Marichal-Gallardo
All genres
Journal Article (9)
1.
Journal Article
118 (10), pp. 3996 - 4013 (2021)
Towards integrated production of an influenza A vaccine candidate with MDCK suspension cells. Biotechnology and Bioengineering 2.
Journal Article
118 (12), pp. 4720 - 4734 (2021)
A high cell density perfusion process for Modified Vaccinia virus Ankara production: process integration with inline DNA digestion and cost analysis. Biotechnology and Bioengineering 3.
Journal Article
19 (1), 91 (2021)
Cell culture-based production and in vivo characterization of purely clonal defective interfering influenza virus particles. BMC Biology 4.
Journal Article
105 (1), pp. 129 - 146 (2021)
OP7, a novel influenza A virus defective interfering particle: production, purification, and animal experiments demonstrating antiviral potential. Applied Microbiology and Biotechnology 5.
Journal Article
13 (8), pp. 1981 - 1989 (2021)
Multi-enzyme cascades for the in vitro synthesis of guanosine diphosphate L-fucose. ChemCatChem 6.
Journal Article
32 (17-18), pp. 959 - 974 (2021)
Single-use capture purification of adeno-associated viral gene transfer vectors by membrane-based steric exclusion chromatography. Human Gene Therapy 7.
Journal Article
10 (7), 1756 (2021)
Antiviral Activity of Influenza A Virus Defective Interfering Particles against SARS-CoV-2 Replication In Vitro through Stimulation of Innate Immunity. Cells 8.
Journal Article
37 (47), pp. 7019 - 7028 (2019)
Efficient influenza A virus production in high cell density using the novel porcine suspension cell line PBG.PK2.1. Vaccine 9.
Journal Article
1483 (3), pp. 110 - 119 (2017)
Steric exclusion chromatography for purification of cell culture-derived influenza A virus using regenerated cellulose membranes and polyethylene glycol. Journal of Chromatography A Meeting Abstract (2)
10.
Meeting Abstract
A single-use chromatographic purification platform for viral gene transfer vectors & viral vaccines. In Proceedings Advancing Manufacture of Cell and Gene Therapies VI, 92. Advancing Manufacture of Cell and Gene Therapies VI, Loews Coronado Bay Hotel Coronado, California, USA, January 27, 2019 - January 31, 2019. (2019)
11.
Meeting Abstract
Purifying viruses with a sheet of paper: Single-use steric exclusion chromatography as a capture platform for vaccine candidates. In Vaccine Technology VII, 128. Vaccine Technology VII, Mont Tremblant, Canada, June 17, 2018 - June 22, 2018. (2018)
Talk (7)
12.
Talk
Influenza A Virus Defective Interfering Particles for Antiviral Treatment of the Influenza Disease and COVID-19. 31st Annual Meeting of the Society for Virology, online (2022)
13.
Talk
A single-use chromatographic purification platform for viral gene transfer vectors & viral vaccines. ECI Advancing Manufacture of Cell and Gene Therapies VI, Coronado, United States of America (2019)
14.
Talk
Moderne Methoden der Impfstoffherstellung. Wissenschaft im Rathaus, Magdeburg, Germany (2019)
15.
Talk
Cell Culture-based Viral Vaccines: Process Intensification and Monitoring. Cuba Symposium “Frontiers of Science”, Havanna, Cuba (2019)
16.
Talk
A universal platform for continuous manufacturing of viral vaccines & gene therapy vectors. Workshop Bioverfahrenstechnik, Leuna, Germany (2019)
17.
Talk
A single-use purification platform for viral vaccines & gene therapy vectors. International Symposium on the Separation of Proteins, Peptides, and Polynucleotides (ISPPP) 2018, Berlin, Germany (2018)
18.
Talk
Single-use purification of cell culture-based virus particles by steric exclusion chromatography. National Meeting of the American Chemical Society (ACS), New Orleans, USA (2018)
Poster (3)
19.
Poster
Influenza A Virus Defective Interfering Particles for Antiviral Treatment of the Influenza Disease and COVID-19. 31st Annual Meeting of the Society for Virology, online (2022)
20.
Poster
The novel influenza A virus defective interfering particle "OP7" as an antiviral agent: discovery, production, and animal trials. The seventh ESWI Influenza Conference, Virtual Meeting (2020)